Cargando…

Impact on life expectancy of HIV-1 positive individuals of CD4(+) cell count and viral load response to antiretroviral therapy

OBJECTIVE: The objective of this study is to estimate life expectancies of HIV-positive patients conditional on response to antiretroviral therapy (ART). METHODS: Patients aged more than 20 years who started ART during 2000–2010 (excluding IDU) in HIV clinics contributing to the UK CHIC Study were f...

Descripción completa

Detalles Bibliográficos
Autores principales:	May, Margaret T., Gompels, Mark, Delpech, Valerie, Porter, Kholoud, Orkin, Chloe, Kegg, Stephen, Hay, Phillip, Johnson, Margaret, Palfreeman, Adrian, Gilson, Richard, Chadwick, David, Martin, Fabiola, Hill, Teresa, Walsh, John, Post, Frank, Fisher, Martin, Ainsworth, Jonathan, Jose, Sophie, Leen, Clifford, Nelson, Mark, Anderson, Jane, Sabin, Caroline
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2014
Materias:	Epidemiology and Social
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004637/ https://www.ncbi.nlm.nih.gov/pubmed/24556869 http://dx.doi.org/10.1097/QAD.0000000000000243

Ejemplares similares

Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study
por: May, Margaret, et al.
Publicado: (2011)

Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapy
por: Jose, Sophie, et al.
Publicado: (2014)

Incomplete Reversibility of Estimated Glomerular Filtration Rate Decline Following Tenofovir Disoproxil Fumarate Exposure
por: Jose, Sophie, et al.
Publicado: (2014)

Hepatitis B, hepatitis C, and mortality among HIV-positive individuals
por: Thornton, Alicia C., et al.
Publicado: (2017)

Virological failure and development of new resistance mutations according to CD4 count at combination antiretroviral therapy initiation
por: Jose, S, et al.
Publicado: (2015)

Life expectancy of HIV-1-positive individuals approaches normal conditional on response to antiretroviral therapy: UK Collaborative HIV Cohort Study
por: May, M, et al.
Publicado: (2012)

The effects of age on associations between markers of HIV progression and markers of metabolic function including albumin, haemoglobin and lipid concentrations
por: Samuel, M, et al.
Publicado: (2014)

Virological outcomes of boosted protease inhibitor-based first-line ART in subjects harbouring thymidine analogue-associated mutations as the sole form of transmitted drug resistance
por: Geretti, Anna Maria, et al.
Publicado: (2019)

Impact on life expectancy of late diagnosis and treatment of HIV-1 infected individuals: UK CHIC
por: May, MT, et al.
Publicado: (2010)

Benchmarked performance charts using principal components analysis to improve the effectiveness of feedback for audit data in HIV care
por: Michael, Skevi, et al.
Publicado: (2017)

Neurocognitive Function in HIV Infected Patients on Antiretroviral Therapy
por: Winston, Alan, et al.
Publicado: (2013)

Durability of viral suppression with first-line antiretroviral therapy in patients with HIV in the UK: an observational cohort study
por: O'Connor, Jemma, et al.
Publicado: (2017)

A continuum of HIV care describing mortality and loss to follow-up: a longitudinal cohort study
por: Jose, Sophie, et al.
Publicado: (2018)

Development and application of a new measure of engagement in out‐patient HIV care
por: Howarth, AR, et al.
Publicado: (2016)

A qualitative study exploring the social and environmental context of recently acquired HIV infection among men who have sex with men in South-East England
por: Gourlay, Annabelle, et al.
Publicado: (2017)

Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy?
por: Sabin, Caroline A
Publicado: (2013)

Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trial
por: Paton, Nicholas I, et al.
Publicado: (2015)

Low frequency of genotypic resistance in HIV-1-infected patients failing an atazanavir-containing regimen: a clinical cohort study
por: Dolling, David I., et al.
Publicado: (2013)

Patients’ expectations versus doctors’ expectations in antiretroviral therapy
por: Largu, Alexandra Maria, et al.
Publicado: (2014)

The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UK
por: Inshaw, Jamie, et al.
Publicado: (2015)

A tale of two countries: all‐cause mortality among people living with HIV and receiving combination antiretroviral therapy in the UK and Canada
por: Patterson, S, et al.
Publicado: (2017)

Pretreatment CD4 Cell Slope and Progression to AIDS or Death in HIV-Infected Patients Initiating Antiretroviral Therapy—The CASCADE Collaboration: A Collaboration of 23 Cohort Studies
por: Wolbers, Marcel, et al.
Publicado: (2010)

The menopause transition in women living with HIV: current evidence and future avenues of research
por: Tariq, Shema, et al.
Publicado: (2016)

Emergent Resistance to Dolutegravir Among INSTI-Naïve Patients on First-line or Second-line Antiretroviral Therapy: A Review of Published Cases
por: Cevik, Muge, et al.
Publicado: (2020)

Mind the gap: difference between Framingham heart age and real age increases with age in HIV-positive individuals–a clinical cohort study
por: Davies, Teri-Louise, et al.
Publicado: (2013)

Attitudes and beliefs towards early ART initiation in MSM with primary HIV infection
por: Parsons, Victoria, et al.
Publicado: (2014)

Risk factors and outcomes for the Q151M and T69 insertion HIV-1 resistance mutations in historic UK data
por: Stirrup, Oliver T., et al.
Publicado: (2018)

Discordant CSF/plasma HIV-1 RNA in patients with unexplained low-level viraemia
por: Nightingale, Sam, et al.
Publicado: (2016)

Clinical Progression Rates by CD4 Cell Category Before and After the Initiation of Combination Antiretroviral Therapy (cART)
por: Guiguet, Marguerite, et al.
Publicado: (2008)

Multitype violence exposures and adolescent antiretroviral nonadherence in South Africa
por: Cluver, Lucie, et al.
Publicado: (2018)

Should Expectations about the Rate of New Antiretroviral Drug Development Impact the Timing of HIV Treatment Initiation and Expectations about Treatment Benefits?
por: Khademi, Amin, et al.
Publicado: (2014)

Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America
por: Helleberg, Marie, et al.
Publicado: (2015)

Attitudes of People in the UK with HIV Who Are Antiretroviral (ART) Naïve to Starting ART at High CD4 Counts for Potential Health Benefit or to Prevent HIV Transmission
por: Rodger, Alison J., et al.
Publicado: (2014)

Trends in HIV testing in the UK primary care setting: a 15-year retrospective cohort study from 2000 to 2015
por: Gompels, Mark, et al.
Publicado: (2019)

Hepmarc: A 96 week randomised controlled feasibility trial of add-on maraviroc in people with HIV and non-alcoholic fatty liver disease
por: Bradshaw, Daniel, et al.
Publicado: (2023)

CSF/plasma HIV-1 RNA discordance even at low levels is associated with up-regulation of host inflammatory mediators in CSF()
por: Nightingale, Sam, et al.
Publicado: (2016)

Role of HIV Infection Duration and CD4 Cell Level at Initiation of Combination Anti-Retroviral Therapy on Risk of Failure
por: Lodi, Sara, et al.
Publicado: (2013)

The impact of transient combination antiretroviral treatment in early HIV infection on viral suppression and immunologic response in later treatment
por: Pantazis, Nikos, et al.
Publicado: (2016)

Personalized life expectancy and treatment benefit index of antiretroviral therapy
por: Xiao, Yanni, et al.
Publicado: (2017)

Real-world persistence with antiretroviral therapy for HIV in the United Kingdom: A multicentre retrospective cohort study
por: Lewis, Joseph M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b3h7qphiht62gumc7g2locrd3k